Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) FCF Margin (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed FCF Margin for 12 consecutive years, with 481.59% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 76186.0% year-over-year to 481.59%, compared with a TTM value of 690.86% through Dec 2025, up 37812.0%, and an annual FY2025 reading of 690.86%, up 37812.0% over the prior year.
  • FCF Margin was 481.59% for Q4 2025 at Agios Pharmaceuticals, up from 674.27% in the prior quarter.
  • Across five years, FCF Margin topped out at 481.59% in Q4 2025 and bottomed at 12084.01% in Q1 2022.
  • Average FCF Margin over 4 years is 1808.72%, with a median of 1127.82% recorded in 2023.
  • The sharpest move saw FCF Margin surged 1037993bps in 2023, then plummeted -20906bps in 2024.
  • Year by year, FCF Margin stood at 1537.73% in 2022, then skyrocketed by 33bps to 1034.39% in 2023, then dropped by -20bps to 1243.46% in 2024, then soared by 61bps to 481.59% in 2025.
  • Business Quant data shows FCF Margin for AGIO at 481.59% in Q4 2025, 674.27% in Q3 2025, and 630.62% in Q2 2025.